| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $194,951,016 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01HL181234 | Optimizing and evaluating an implementation strategy to improve use of classroom-based physical activity approaches in elementary schools | 000 | 1 | NIH | 7/7/2026 | $794,406 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | U01AG095419 | Mitochondrial Energetic Failures in Men and Women Across Trajectories of Alzheimer Disease | 000 | 1 | NIH | 8/19/2026 | $2,261,339 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | U01AG095419 | Mitochondrial Energetic Failures in Men and Women Across Trajectories of Alzheimer Disease | 003 | 1 | NIH | 9/16/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R21MD019363 | Increasing Mothers' Own Milk Feeding to Black Infants in the Neonatal ICU: Training a Lactation Team in a Culturally Informed Behavioral Intervention | 000 | 1 | NIH | 6/23/2026 | $234,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | F31MH143524 | Investigating the role of prefrontal cortex circuits in risky decision-making | 002 | 1 | NIH | 7/21/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | F31MH143524 | Investigating the role of prefrontal cortex circuits in risky decision-making | 001 | 1 | NIH | 7/21/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | F31MH143524 | Investigating the role of prefrontal cortex circuits in risky decision-making | 000 | 1 | NIH | 6/23/2026 | $38,264 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | RF1MH143737 | Improving Care Coordination Across Behavioral Health Settings: The Role of Payment and Delivery Innovations for Adults with Serious Mental Illness | 000 | 1 | NIH | 6/23/2026 | $3,161,010 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R35GM163872 | Structural and Mechanistic Studies of Eukaryotic Gene Transcription Regulation | 000 | 1 | NIH | 7/6/2026 | $420,476 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | K01HL183853 | Developing a multi-component implementation strategy to increase physical activity in Pre-Kindergarten classrooms | 000 | 1 | NIH | 8/24/2026 | $153,063 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R21CA301364 | Identifying Mechanisms of Implementation Strategies for Cancer Control: An Implementation Mapping Approach | 000 | 1 | NIH | 3/30/2026 | $401,115 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | K01DK144335 | Role of Neutrophil-derived HIF1a signaling in Hepatic Ischemia/Reperfusion Injury | 000 | 1 | NIH | 5/4/2026 | $158,220 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01AG094056 | Contribution of intramural von Willebrand factor (VWF) to cerebrovascular dysfunction in amyloidosis | 000 | 1 | NIH | 1/22/2026 | $650,533 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | U01AG098387 | PG4AD: Scaling up pangenome graph for genotyping complex structural variations for Alzheimer's disease genetics | 001 | 1 | NIH | 8/17/2026 | -$556,358 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | U01AG098387 | PG4AD: Scaling up pangenome graph for genotyping complex structural variations for Alzheimer's disease genetics | 003 | 1 | NIH | 8/26/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | U01AG098387 | PG4AD: Scaling up pangenome graph for genotyping complex structural variations for Alzheimer's disease genetics | 000 | 1 | NIH | 2/17/2026 | $556,359 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | K08HD120866 | The Role of Gut Microbiota-Derived Butyrate in Inflammation and Neurological Outcomes after Neonatal Hypoxic-Ischemic Encephalopathy | 001 | 1 | NIH | 5/1/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | K08HD120866 | The Role of Gut Microbiota-Derived Butyrate in Inflammation and Neurological Outcomes after Neonatal Hypoxic-Ischemic Encephalopathy | 000 | 1 | NIH | 3/27/2026 | $162,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R35GM163868 | Structure and Function of a Metabolic Network Coordinating Membrane Phospholipid Homeostasis in Microorganisms | 000 | 1 | NIH | 7/8/2026 | $429,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01CA316689 | Rewired Golgi secretion creates a therapeutic vulnerability in chromosome 3q-amplified NSCLC. | 000 | 1 | NIH | 7/23/2026 | $635,948 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01AG098122 | Biomarkers and Pathogenesis of Perioperative Neurocognitive Disorders | 001 | 1 | NIH | 9/1/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01AG098122 | Biomarkers and Pathogenesis of Perioperative Neurocognitive Disorders | 000 | 1 | NIH | 7/31/2026 | $580,798 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | RF1MH131570 | Corticothalamic circuits mediating behavioral adaptations to unexpected reward omission | 000 | 4 | NIH | 4/27/2026 | $1,202,292 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01MH143017 | Developing Biomarker-Supported SSD Prevention | 000 | 1 | NIH | 7/8/2026 | $777,176 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R61NS151436 | Development and validation of an alpha-synuclein Seed Amplification Assay using peripheral bodily fluids of patients affected by Parkinson's disease and Dementia with Lewy bodies | 000 | 1 | NIH | 8/31/2026 | $722,153 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01AR087804 | Hypoxia-Driven NUDT21-Mediated APA Promotes Lung and Skin Fibrosis in Systemic Sclerosis | 000 | 1 | NIH | 6/19/2026 | $623,286 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R03NS144937 | Enhancing Stroke Recurrent Event Risk Prediction with Boosting and Transfer Learning | 000 | 1 | NIH | 6/16/2026 | $78,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R34HL182386 | Preparing for Semaglutide Microdosing to Maintain Cardiovascular Health in People with HIV: The (pre-)SMASH CVD Trial | 000 | 1 | NIH | 7/8/2026 | $255,458 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01DE035094 | OpenMouth: Leveraging AI to Enhance Fairness in Dental Clinical Research | 000 | 1 | NIH | 7/8/2026 | $721,776 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01CA295608 | Targeting the Golgi Secretory Pathway in Chromosome 3q-amplified Human Cancer | 000 | 1 | NIH | 5/22/2026 | $388,546 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | T42OH008421 | Southwest Center for Occupational and Environmental Health | 00 | 19 | CDC | 8/3/2026 | $1,700,109 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R21HL184915 | Unlocking Hidden Concurrent Symptom Burdens and Estimating Their Associations with Health Outcomes in People Living with HIV and Co-Morbid Diabetes and Hypertension Through Topic Modeling | 000 | 1 | NIH | 8/28/2026 | $234,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | U24AG098157 | ReCARDO: Using Real-World Data to Derive Common Data Elements for Alzheimer's Disease and AD-Related Dementias Research Through Ontological Innovation | 000 | 2 | NIH | 8/20/2026 | $5,804,982 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R21AG098442 | Drosophila vitellogenic oocytes as an in vivo model to dissect the regulatory mechanism for low-density lipoprotein receptor-related protein 1 | 000 | 1 | NIH | 7/3/2026 | $421,225 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | K22CA293300 | Modeling Enhancer Hijacking in Cancer via Genome Engineering and Single-Cell Sequencing | 000 | 2 | NIH | 8/27/2026 | $194,914 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01AG082314 | Microglial regulation of neuronal activity in TDP-43 neurodegeneration | 000 | 3 | NIH | 4/9/2026 | $711,702 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | RF1NS144915 | Mechanism-guided amelioration of hyperactivity in human and rodent nociceptors linked to spontaneous pain | 000 | 1 | NIH | 9/19/2026 | $2,330,525 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R21AR088832 | Nuclear Receptors In Cancer Cachexia | 000 | 1 | NIH | 9/22/2026 | $200,604 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01NR022435 | Discovery of Symptom Burdens and Their Associations with Health Outcomes among People Living with HIV | 000 | 1 | NIH | 9/19/2026 | $27,548 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01NR022435 | Discovery of Symptom Burdens and Their Associations with Health Outcomes among People Living with HIV | 000 | 1 | NIH | 9/19/2026 | $374,807 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | DP2AI192743 | The role of carbon dioxide in mediating host-parasite interactions in a skin-penetrating nematode | 000 | 1 | NIH | 9/18/2026 | $455,680 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R24HL180372 | POI-KB: Design and Development of a Knowledgebase for Accelerating Perioperative Organ Injury Research and Translation | 000 | 2 | NIH | 9/3/2026 | $100,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | K23NS144706 | Novel CT-based Biomarkers to Improve Acute Stroke Triage | 000 | 1 | NIH | 9/7/2026 | $217,080 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01AG063946 | Twenty-four hour patterns of light and activity and Alzheimer's Disease and Related Dementia: interplay with multi-omics biomarkers and AD pathogenesis pathways | 001 | 5 | NIH | 9/4/2026 | $736,403 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01DA067060 | Psilocybin-Assisted ACT for Co-Occurring Cocaine Use Disorder and Major Depressive Disorder | 001 | 1 | NIH | 9/18/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | K07AG097560 | Establishing Houston as a regional hub for Biology of Aging research | 000 | 1 | NIH | 9/7/2026 | $162,000 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R01DA067060 | Psilocybin-Assisted ACT for Co-Occurring Cocaine Use Disorder and Major Depressive Disorder | 000 | 1 | NIH | 9/1/2026 | $699,431 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | R00DE033506 | A signaling crosstalk regulation in neural crest-derived cranial suture | 000 | 3 | NIH | 9/8/2026 | $248,999 |
| | 2026 | 2026 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | 7000 FANNIN ST FL 9 | HOUSTON | TX | 77030-3870 | HARRIS | USA | UH3NS139014 | An innovative device for management of neuropathic pain after spinal cord injury | 000 | 2 | NIH | 9/17/2026 | $800,027 |
|
